메뉴 건너뛰기




Volumn 26, Issue 1, 2010, Pages 82-91

Update on management of seminoma

Author keywords

Carboplatin; Chemotherapy; Orchidectomy; Radiotherapy; Seminoma; Surgery; Surveillance; Testicular germ cell tumors

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; PACLITAXEL; VINBLASTINE;

EID: 77950555439     PISSN: 09701591     EISSN: 19983824     Source Type: Journal    
DOI: 10.4103/0970-1591.60451     Document Type: Conference Paper
Times cited : (11)

References (104)
  • 1
    • 0037112184 scopus 로고    scopus 로고
    • Prognostic factors for relapse in stage i seminoma managed by surveillance: A pooled analysis
    • Warde P, Specht L, Horwich A, Oliver T, Panzarella T, Gospodarowicz M, et al., Prognostic factors for relapse in stage I seminoma managed by surveillance: A pooled analysis. J Clin Oncol 2002;20:4448-4452
    • (2002) J Clin Oncol , vol.20 , pp. 4448-4452
    • Warde, P.1    Specht, L.2    Horwich, A.3    Oliver, T.4    Panzarella, T.5    Gospodarowicz, M.6
  • 2
    • 33845757611 scopus 로고    scopus 로고
    • Treatment options, prognostic factors and selection of treatment in stage i seminoma
    • Martin J, Chung P, Warde P. Treatment options, prognostic factors and selection of treatment in stage I seminoma. Onkologie 2006;29:592-598
    • (2006) Onkologie , vol.29 , pp. 592-598
    • Martin, J.1    Chung, P.2    Warde, P.3
  • 3
    • 38949169584 scopus 로고    scopus 로고
    • European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part i
    • Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, et al. European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2008;53:478-496
    • (2008) Eur Urol , vol.53 , pp. 478-496
    • Krege, S.1    Beyer, J.2    Souchon, R.3    Albers, P.4    Albrecht, W.5    Algaba, F.6
  • 5
    • 0037504532 scopus 로고    scopus 로고
    • Cardiovascular disease as a long-term complication of treatment for testicular cancer
    • Huddart RA, Norman A, Shahidi M, Horwich A, Coward D, Nicholls J, et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 2003;21:1513-1523
    • (2003) J Clin Oncol , vol.21 , pp. 1513-1523
    • Huddart, R.A.1    Norman, A.2    Shahidi, M.3    Horwich, A.4    Coward, D.5    Nicholls, J.6
  • 9
    • 0028354951 scopus 로고
    • Mortality and cancer incidence following radiotherapy for seminoma of the testis
    • Horwich A, Bell J. Mortality and cancer incidence following radiotherapy for seminoma of the testis. Radiother Oncol 1994;30:193-198
    • (1994) Radiother Oncol , vol.30 , pp. 193-198
    • Horwich, A.1    Bell, J.2
  • 10
    • 0025220320 scopus 로고
    • Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy
    • Fosså SD, Langmark F, Aass N, Andersen A, Lothe R, Børresen AL. Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy. Br J Cancer 1990;61:639-643
    • (1990) Br J Cancer , vol.61 , pp. 639-643
    • Fosså, S.D.1    Langmark, F.2    Aass, N.3    Andersen, A.4    Lothe, R.5    Børresen, A.L.6
  • 11
    • 0031715844 scopus 로고    scopus 로고
    • Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer
    • Gyenes G, Rutqvist LE, Liedberg A, Fornander T. Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. Radiother Oncol 1998;48:185-190
    • (1998) Radiother Oncol , vol.48 , pp. 185-190
    • Gyenes, G.1    Rutqvist, L.E.2    Liedberg, A.3    Fornander, T.4
  • 12
    • 0025374837 scopus 로고
    • Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry
    • Rutqvist LE, Johansson H. Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry. Br J Cancer 1990;61:866-868
    • (1990) Br J Cancer , vol.61 , pp. 866-868
    • Rutqvist, L.E.1    Johansson, H.2
  • 13
    • 0026715803 scopus 로고
    • Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer
    • Rutqvist LE, Lax I, Fornander T, Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 1992;22:887-896
    • (1992) Int J Radiat Oncol Biol Phys , vol.22 , pp. 887-896
    • Rutqvist, L.E.1    Lax, I.2    Fornander, T.3    Johansson, H.4
  • 15
    • 0025250141 scopus 로고
    • Irradiation-related ischemic heart disease
    • Corn BW, Trock BJ, Goodman RL. Irradiation-related ischemic heart disease. J Clin Oncol 1990;8:741-750
    • (1990) J Clin Oncol , vol.8 , pp. 741-750
    • Corn, B.W.1    Trock, B.J.2    Goodman, R.L.3
  • 16
    • 0028279135 scopus 로고
    • Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy
    • Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994;12:447-453
    • (1994) J Clin Oncol , vol.12 , pp. 447-453
    • Cuzick, J.1    Stewart, H.2    Rutqvist, L.3    Houghton, J.4    Edwards, R.5    Redmond, C.6
  • 18
    • 0026440522 scopus 로고
    • Seminoma of the testis: Long-term beneficial and deleterious results of radiation
    • Hanks GE, Peters T, Owen J. Seminoma of the testis: Long-term beneficial and deleterious results of radiation. Int J Radiat Oncol Biol Phys 1992;24:913-919
    • (1992) Int J Radiat Oncol Biol Phys , vol.24 , pp. 913-919
    • Hanks, G.E.1    Peters, T.2    Owen, J.3
  • 19
    • 0008292789 scopus 로고    scopus 로고
    • Optimal planning target volume for stage i testicular seminoma: A Medical Research Council randomized trial
    • Fosså SD, Horwich A, Russell JM, Roberts JT, Cullen MH, Hodson NJ, et al. Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. J Clin Oncol 1999;17:1146.
    • (1999) J Clin Oncol , vol.17 , pp. 1146
    • Fosså, S.D.1    Horwich, A.2    Russell, J.M.3    Roberts, J.T.4    Cullen, M.H.5    Hodson, N.J.6
  • 20
    • 14544272797 scopus 로고    scopus 로고
    • Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage i Testicular Seminoma: A report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328)
    • Jones WG, Fossa SD, Mead GM, Roberts JT, Sokal M, Horwich A, et al. Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: A report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). J Clin Oncol 2005;23:1200-1208
    • (2005) J Clin Oncol , vol.23 , pp. 1200-1208
    • Jones, W.G.1    Fossa, S.D.2    Mead, G.M.3    Roberts, J.T.4    Sokal, M.5    Horwich, A.6
  • 21
    • 22544476802 scopus 로고    scopus 로고
    • Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage i seminoma: A randomized trial
    • Oliver RT, Mason MD, Mead GM, von der Maase H, Rustin GJ, Joffe JK, et al. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: A randomized trial. Lancet 2005;366:293-300.
    • (2005) Lancet , vol.366 , pp. 293-300
    • Oliver, R.T.1    Mason, M.D.2    Mead, G.M.3    Von Der Maase, H.4    Rustin, G.J.5    Joffe, J.K.6
  • 22
    • 0030001271 scopus 로고    scopus 로고
    • Omission of the pelvic irradiation in stage i testicular seminoma: A study of postorchiectomy paraaortic radiotherapy
    • Kiricuta IC, Sauer J, Bohndorf W. Omission of the pelvic irradiation in stage I testicular seminoma: A study of postorchiectomy paraaortic radiotherapy. Int J Radiat Oncol Biol Phys 1996;35:293-298
    • (1996) Int J Radiat Oncol Biol Phys , vol.35 , pp. 293-298
    • Kiricuta, I.C.1    Sauer, J.2    Bohndorf, W.3
  • 23
    • 3042699830 scopus 로고    scopus 로고
    • Para-aortic irradiation for stage i testicular seminoma: Results of a prospective study in 675 patients: A trial of the German testicular cancer study group (GTCSG)
    • Classen J, Schmidberger H, Meisner C, Winkler C, Dunst J, Souchon R, et al. Para-aortic irradiation for stage I testicular seminoma: Results of a prospective study in 675 patients: A trial of the German testicular cancer study group (GTCSG). Br J Cancer 2004;90:2305-2311
    • (2004) Br J Cancer , vol.90 , pp. 2305-2311
    • Classen, J.1    Schmidberger, H.2    Meisner, C.3    Winkler, C.4    Dunst, J.5    Souchon, R.6
  • 28
    • 73149108706 scopus 로고    scopus 로고
    • Surveillance in stage i seminoma patients: A long-term assessment
    • [In press]
    • Cummins S, Yau T, Huddart R, Dearnaley D, Horwich A. Surveillance in stage I seminoma patients: A long-term assessment. Eur Urol 2009. [In press]
    • (2009) Eur Urol
    • Cummins, S.1    Yau, T.2    Huddart, R.3    Dearnaley, D.4    Horwich, A.5
  • 30
    • 13844280925 scopus 로고    scopus 로고
    • Long-term outcome of postorchiectomy surveillance for Stage i testicular seminoma
    • Choo R, Thomas G, Woo T, Lee D, Kong B, Iscoe N, et al., Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma. Int J Radiat Oncol Biol Phys 2005;61:736-740
    • (2005) Int J Radiat Oncol Biol Phys , vol.61 , pp. 736-740
    • Choo, R.1    Thomas, G.2    Woo, T.3    Lee, D.4    Kong, B.5    Iscoe, N.6
  • 31
    • 0029842644 scopus 로고    scopus 로고
    • Adjuvant radiation versus observation: A cost analysis of alternate management schemes in early-stage testicular seminoma
    • Sharda NN, Kinsella TJ, Ritter MA. Adjuvant radiation versus observation: A cost analysis of alternate management schemes in early-stage testicular seminoma. J Clin Oncol 1996;14:2933-2939
    • (1996) J Clin Oncol , vol.14 , pp. 2933-2939
    • Sharda, N.N.1    Kinsella, T.J.2    Ritter, M.A.3
  • 33
    • 0028198505 scopus 로고
    • Pilot studies of 2 and 1 course carboplatin as adjuvant for stage i seminoma: Should it be tested in a randomized trial against radiotherapy?
    • Oliver RT, Edmonds PM, Ong JY, Ostrowski MJ, Jackson AW, Baille- Johnson H, et al. Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: Should it be tested in a randomized trial against radiotherapy? Int J Radiat Oncol Biol Phys 1994;29:3-8.
    • (1994) Int J Radiat Oncol Biol Phys , vol.29 , pp. 3-8
    • Oliver, R.T.1    Edmonds, P.M.2    Ong, J.Y.3    Ostrowski, M.J.4    Jackson, A.W.5    Baille- Johnson, H.6
  • 34
    • 33644660123 scopus 로고    scopus 로고
    • Risk-adapted management for patients with clinical stage i seminoma: The Second Spanish Germ Cell Cancer Cooperative Group study
    • Aparicio J, Germà JR, García del Muro X, Maroto P, Arranz JA, Sáenz A, et al. Risk-adapted management for patients with clinical stage I seminoma: The Second Spanish Germ Cell Cancer Cooperative Group study. J Clin Oncol 2005;23:8717-8723
    • (2005) J Clin Oncol , vol.23 , pp. 8717-8723
    • Aparicio, J.1    Germà, J.R.2    García Del Muro, X.3    Maroto, P.4    Arranz, J.A.5    Sáenz, A.6
  • 35
    • 44949179724 scopus 로고    scopus 로고
    • Evidence-based pragmatic guidelines for the follow-up of testicular cancer: Optimising the detection of relapse
    • van As NJ, Gilbert DC, Money-Kyrle J, Bloomfield D, Beesley S, Dearnaley DP, et al. Evidence-based pragmatic guidelines for the follow-up of testicular cancer: Optimising the detection of relapse. Br J Cancer 2008;98:1894-1902
    • (2008) Br J Cancer , vol.98 , pp. 1894-1902
    • Van As, N.J.1    Gilbert, D.C.2    Money-Kyrle, J.3    Bloomfield, D.4    Beesley, S.5    Dearnaley, D.P.6
  • 36
    • 36549007486 scopus 로고    scopus 로고
    • Computed tomography: An increasing source of radiation exposure
    • Brenner DJ, Hall EJ. Computed tomography: An increasing source of radiation exposure. N Engl J Med 2007;357:2277-2284
    • (2007) N Engl J Med , vol.357 , pp. 2277-2284
    • Brenner, D.J.1    Hall, E.J.2
  • 37
    • 0036321566 scopus 로고    scopus 로고
    • Long-term experience with carboplatin monotherapy for clinical stage i seminoma: A retrospective single-center study
    • Steiner H, Höltl L, Wirtenberger W, Berger AP, Bartsch G, Hobisch A, et al. Long-term experience with carboplatin monotherapy for clinical stage I seminoma: A retrospective single-center study. Urology 2002;60:324-328
    • (2002) Urology , vol.60 , pp. 324-328
    • Steiner, H.1    Höltl, L.2    Wirtenberger, W.3    Berger, A.P.4    Bartsch, G.5    Hobisch, A.6
  • 38
    • 0030985234 scopus 로고    scopus 로고
    • Phase II study: Adjuvant single-agent carboplatin therapy for clinical stage i seminoma
    • Krege S, Kalund G, Otto T, Goepel M, Rübben H, Phase II study: Adjuvant single-agent carboplatin therapy for clinical stage I seminoma. Eur Urol 1997;31:405-407
    • (1997) Eur Urol , vol.31 , pp. 405-407
    • Krege, S.1    Kalund, G.2    Otto, T.3    Goepel, M.4    Rübben, H.5
  • 39
    • 0035151394 scopus 로고    scopus 로고
    • Twelve-year experience with two courses of adjuvant singleagent carboplatin therapy for clinical stage i seminoma
    • Reiter WJ, Brodowicz T, Alavi S, Zielinski CC, Kozak W, Maier U, et al. Twelve-year experience with two courses of adjuvant singleagent carboplatin therapy for clinical stage I seminoma. J Clin Oncol 2001;19:101-104
    • (2001) J Clin Oncol , vol.19 , pp. 101-104
    • Reiter, W.J.1    Brodowicz, T.2    Alavi, S.3    Zielinski, C.C.4    Kozak, W.5    Maier, U.6
  • 43
    • 40149089203 scopus 로고    scopus 로고
    • The long-term risks of adjuvant carboplatin treatment for stage i seminoma of the testis
    • Powles T, Robinson D, Shamash J, Moller H, Tranter N, Oliver T. The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann Oncol 2008;19:443-447
    • (2008) Ann Oncol , vol.19 , pp. 443-447
    • Powles, T.1    Robinson, D.2    Shamash, J.3    Moller, H.4    Tranter, N.5    Oliver, T.6
  • 44
    • 33644648880 scopus 로고    scopus 로고
    • Testicular germ-cell cancer
    • Horwich A, Shipley J, Huddart R. Testicular germ-cell cancer. Lancet 2006;367:754-765
    • (2006) Lancet , vol.367 , pp. 754-765
    • Horwich, A.1    Shipley, J.2    Huddart, R.3
  • 46
    • 0028989157 scopus 로고
    • Radiotherapy for stages i and II testicular seminoma: Results and morbidity in 238 patients
    • Vallis KA, Howard GC, Duncan W, Cornbleet MA, Kerr GR. Radiotherapy for stages I and II testicular seminoma: Results and morbidity in 238 patients. Br J Radiol 1995;68:400-405
    • (1995) Br J Radiol , vol.68 , pp. 400-405
    • Vallis, K.A.1    Howard, G.C.2    Duncan, W.3    Cornbleet, M.A.4    Kerr, G.R.5
  • 48
    • 0037445189 scopus 로고    scopus 로고
    • Radiotherapy for stages IIA/B testicular seminoma: Final report of a prospective multicenter clinical trial
    • Classen J, Schmidberger H, Meisner C, Souchon R, Sautter-Bihl ML, Sauer R, et al. Radiotherapy for stages IIA/B testicular seminoma: Final report of a prospective multicenter clinical trial. J Clin Oncol 2003;21:1101-1106
    • (2003) J Clin Oncol , vol.21 , pp. 1101-1106
    • Classen, J.1    Schmidberger, H.2    Meisner, C.3    Souchon, R.4    Sautter-Bihl, M.L.5    Sauer, R.6
  • 52
    • 38949176745 scopus 로고    scopus 로고
    • European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II
    • Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, et al. European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol 2008;53:497-513.
    • (2008) Eur Urol , vol.53 , pp. 497-513
    • Krege, S.1    Beyer, J.2    Souchon, R.3    Albers, P.4    Albrecht, W.5    Algaba, F.6
  • 53
    • 31544447508 scopus 로고    scopus 로고
    • Single agent carboplatin for CS IIA/B testicular seminoma: A phase II study of the German Testicular Cancer Study Group (GTCSG)
    • Krege S, Boergermann C, Baschek R, Hinke A, Pottek T, Kliesch S, et al. Single agent carboplatin for CS IIA/B testicular seminoma: A phase II study of the German Testicular Cancer Study Group (GTCSG). Ann Oncol 2006;17:276-280
    • (2006) Ann Oncol , vol.17 , pp. 276-280
    • Krege, S.1    Boergermann, C.2    Baschek, R.3    Hinke, A.4    Pottek, T.5    Kliesch, S.6
  • 54
    • 56749175245 scopus 로고    scopus 로고
    • Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: A Spanish Germ Cell Cancer Group Study
    • Garcia-del-Muro X, Maroto P, Gumà J, Sastre J, López Brea M, Arranz JA, et al. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: A Spanish Germ Cell Cancer Group Study. J Clin Oncol 2008;26:5416-5421
    • (2008) J Clin Oncol , vol.26 , pp. 5416-5421
    • Garcia-Del-Muro, X.1    Maroto, P.2    Gumà, J.3    Sastre, J.4    López Brea, M.5    Arranz, J.A.6
  • 55
    • 0035313844 scopus 로고    scopus 로고
    • Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: Comparison with radiotherapy treatment alone
    • Patterson H, Norman AR, Mitra SS, Nicholls J, Fisher C, Dearnaley DP, et al. Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: Comparison with radiotherapy treatment alone. Radiother Oncol 2001;59:5-11.
    • (2001) Radiother Oncol , vol.59 , pp. 5-11
    • Patterson, H.1    Norman, A.R.2    Mitra, S.S.3    Nicholls, J.4    Fisher, C.5    Dearnaley, D.P.6
  • 56
    • 39049130140 scopus 로고    scopus 로고
    • Effect of radiotherapy volume and dose on secondary cancer risk in stage i testicular seminoma
    • Zwahlen DR, Martin JM, Millar JL, Schneider U. Effect of radiotherapy volume and dose on secondary cancer risk in stage I testicular seminoma. Int J Radiat Oncol Biol Phys 2008;70:853-858
    • (2008) Int J Radiat Oncol Biol Phys , vol.70 , pp. 853-858
    • Zwahlen, D.R.1    Martin, J.M.2    Millar, J.L.3    Schneider, U.4
  • 57
    • 35348890176 scopus 로고    scopus 로고
    • Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer
    • van den Belt-Dusebout AW, de Wit R, Gietema JA, Horenblas S, Louwman MW, et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 2007;25:4370-4378
    • (2007) J Clin Oncol , vol.25 , pp. 4370-4378
    • Van Den Belt-Dusebout, A.W.1    De Wit, R.2    Gietema, J.A.3    Horenblas, S.4    Louwman, M.W.5
  • 58
    • 0031037241 scopus 로고    scopus 로고
    • International germ cell consensus classification: A prognostic factorbased staging system for metastatic germ cell cancers
    • International Germ Cell Cancer Collaborative Group
    • International Germ Cell Consensus Classification: A prognostic factorbased staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997;15:594-603.
    • (1997) J Clin Oncol , vol.15 , pp. 594-603
  • 59
    • 0024555713 scopus 로고
    • Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: A Southeastern Cancer Study Group protocol
    • Einhorn LH, Williams SD, Loehrer PJ, Birch R, Drasga R, Omura G, et al. Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: A Southeastern Cancer Study Group protocol. J Clin Oncol 1989;7:387-391
    • (1989) J Clin Oncol , vol.7 , pp. 387-391
    • Einhorn, L.H.1    Williams, S.D.2    Loehrer, P.J.3    Birch, R.4    Drasga, R.5    Omura, G.6
  • 60
    • 0035868896 scopus 로고    scopus 로고
    • Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in goodprognosis germ cell cancer: A randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council
    • de Wit R, Roberts JT, Wilkinson PM, de Mulder PH, Mead GM, Fosså SD, et al. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in goodprognosis germ cell cancer: A randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council. J Clin Oncol 2001;19:1629-1640
    • (2001) J Clin Oncol , vol.19 , pp. 1629-1640
    • De Wit, R.1    Roberts, J.T.2    Wilkinson, P.M.3    De Mulder, P.H.4    Mead, G.M.5    Fosså, S.D.6
  • 61
    • 0031894195 scopus 로고    scopus 로고
    • Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: The Indian University experience
    • Saxman SB, Finch D, Gonin R, Einhorn LH. Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: The Indian University experience. J Clin Oncol 1998;16:702-706
    • (1998) J Clin Oncol , vol.16 , pp. 702-706
    • Saxman, S.B.1    Finch, D.2    Gonin, R.3    Einhorn, L.H.4
  • 62
    • 0037445185 scopus 로고    scopus 로고
    • Quality of life in good prognosis patients with metastatic germ cell cancer: A prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20)
    • Fosså SD, de Wit R, Roberts JT, Wilkinson PM, de Mulder PH, Mead GM, et al. Quality of life in good prognosis patients with metastatic germ cell cancer: A prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20). J Clin Oncol 2003;21:1107-1118
    • (2003) J Clin Oncol , vol.21 , pp. 1107-1118
    • Fosså, S.D.1    De Wit, R.2    Roberts, J.T.3    Wilkinson, P.M.4    De Mulder, P.H.5    Mead, G.M.6
  • 63
    • 17744399298 scopus 로고    scopus 로고
    • A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma: MRC Testicular Tumour Working Party
    • Horwich A, Oliver RT, Wilkinson PM, Mead GM, Harland SJ, Cullen MH, et al. A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma: MRC Testicular Tumour Working Party. Br J Cancer 2000;83:1623-1629
    • (2000) Br J Cancer , vol.83 , pp. 1623-1629
    • Horwich, A.1    Oliver, R.T.2    Wilkinson, P.M.3    Mead, G.M.4    Harland, S.J.5    Cullen, M.H.6
  • 64
    • 4344704483 scopus 로고    scopus 로고
    • Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: A pooled analysis of two randomized trials
    • Bokemeyer C, Kollmannsberger C, Stenning S, Hartmann JT, Horwich A, Clemm C, et al. Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: A pooled analysis of two randomized trials. Br J Cancer 2004;91:683-687
    • (2004) Br J Cancer , vol.91 , pp. 683-687
    • Bokemeyer, C.1    Kollmannsberger, C.2    Stenning, S.3    Hartmann, J.T.4    Horwich, A.5    Clemm, C.6
  • 66
    • 34447341196 scopus 로고    scopus 로고
    • Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: A randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)
    • Culine S, Kerbrat P, Kramar A, Théodore C, Chevreau C, Geoffrois L, et al. Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: A randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP). Ann Oncol 2007;18:917-924
    • (2007) Ann Oncol , vol.18 , pp. 917-924
    • Culine, S.1    Kerbrat, P.2    Kramar, A.3    Théodore, C.4    Chevreau, C.5    Geoffrois, L.6
  • 67
    • 0035836014 scopus 로고    scopus 로고
    • Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumors: A randomized trial
    • Toner GC, Stockler MR, Boyer MJ, Jones M, Thomson DB, Harvey VJ, et al. Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumors: A randomized trial. Lancet 2001;357:739-745
    • (2001) Lancet , vol.357 , pp. 739-745
    • Toner, G.C.1    Stockler, M.R.2    Boyer, M.J.3    Jones, M.4    Thomson, D.B.5    Harvey, V.J.6
  • 68
    • 0031681280 scopus 로고    scopus 로고
    • Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: A randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group
    • European Organization for Research and Treatment of Cancer
    • de Wit R, Stoter G, Sleijfer DT, Neijt JP, ten Bokkel Huinink WW, de Prijck L, et al. Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: A randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Cancer. Br J Cancer 1998;78:828-832
    • (1998) Br J Cancer , vol.78 , pp. 828-832
    • De Wit, R.1    Stoter, G.2    Sleijfer, D.T.3    Neijt, J.P.4    Ten Bokkel Huinink, W.W.5    De Prijck, L.6
  • 69
    • 0031950313 scopus 로고    scopus 로고
    • Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: An Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study
    • Nichols CR, Catalano PJ, Crawford ED, Vogelzang NJ, Einhorn LH, Loehrer PJ. Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: An Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study. J Clin Oncol 1998;16:1287-1293
    • (1998) J Clin Oncol , vol.16 , pp. 1287-1293
    • Nichols, C.R.1    Catalano, P.J.2    Crawford, E.D.3    Vogelzang, N.J.4    Einhorn, L.H.5    Loehrer, P.J.6
  • 70
    • 0030050024 scopus 로고    scopus 로고
    • Hematopoietic growth factors and treatment of testicular cancer: Biological interactions, routine use and dose-intensive chemotherapy
    • Bokemeyer C, Kuczyk MA, Köhne H, Einsele H, Kynast B, Schmoll HJ. Hematopoietic growth factors and treatment of testicular cancer: Biological interactions, routine use and dose-intensive chemotherapy. Ann Hematol 1996;72:1-9.
    • (1996) Ann Hematol , vol.72 , pp. 1-9
    • Bokemeyer, C.1    Kuczyk, M.A.2    Köhne, H.3    Einsele, H.4    Kynast, B.5    Schmoll, H.J.6
  • 71
    • 0030973965 scopus 로고    scopus 로고
    • Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma
    • Miller KD, Loehrer PJ, Gonin R, Einhorn LH, Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma. J Clin Oncol 1997;15:1427-1431
    • (1997) J Clin Oncol , vol.15 , pp. 1427-1431
    • Miller, K.D.1    Loehrer, P.J.2    Gonin, R.3    Einhorn, L.H.4
  • 74
    • 0344734200 scopus 로고    scopus 로고
    • Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor
    • Loehrer PJ Sr, Gonin R, Nichols CR, Weathers T, Einhorn LH. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 1998;16:2500-2504
    • (1998) J Clin Oncol , vol.16 , pp. 2500-2504
    • Loehrer Sr., P.J.1    Gonin, R.2    Nichols, C.R.3    Weathers, T.4    Einhorn, L.H.5
  • 76
    • 25144455744 scopus 로고    scopus 로고
    • A randomized trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumors
    • Pico JL, Rosti G, Kramar A, Wandt H, Koza V, Salvioni R, et al. A randomized trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumors. Ann Oncol 2005;16:1152-1159
    • (2005) Ann Oncol , vol.16 , pp. 1152-1159
    • Pico, J.L.1    Rosti, G.2    Kramar, A.3    Wandt, H.4    Koza, V.5    Salvioni, R.6
  • 77
    • 0036242756 scopus 로고    scopus 로고
    • High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: A matched-pair analysis
    • Beyer J, Stenning S, Gerl A, Fossa S, Siegert W. High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis. Ann Oncol 2002;13:599-605.
    • (2002) Ann Oncol , vol.13 , pp. 599-605
    • Beyer, J.1    Stenning, S.2    Gerl, A.3    Fossa, S.4    Siegert, W.5
  • 78
    • 3142577828 scopus 로고    scopus 로고
    • Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: A study of the German Testicular Cancer Study Group
    • Kollmannsberger C, Beyer J, Liersch R, Schoeffski P, Metzner B, Hartmann JT, et al. Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: A study of the German Testicular Cancer Study Group. J Clin Oncol 2004;22:108-114
    • (2004) J Clin Oncol , vol.22 , pp. 108-114
    • Kollmannsberger, C.1    Beyer, J.2    Liersch, R.3    Schoeffski, P.4    Metzner, B.5    Hartmann, J.T.6
  • 79
    • 0036534301 scopus 로고    scopus 로고
    • Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): A trial of the Eastern Cooperative Oncology Group
    • Hinton S, Catalano P, Einhorn LH, Loehrer PJ Sr, Kuzel T, Vaughn D, et al. Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): A trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2002;20:1859-1863.
    • (2002) J Clin Oncol , vol.20 , pp. 1859-1863
    • Hinton, S.1    Catalano, P.2    Einhorn, L.H.3    Loehrer Sr., P.J.4    Kuzel, T.5    Vaughn, D.6
  • 80
    • 0033015208 scopus 로고    scopus 로고
    • Phase II trial of gemcitabine in refractory germ cell tumors
    • Einhorn LH, Stender MJ, Williams SD. Phase II trial of gemcitabine in refractory germ cell tumors. J Clin Oncol 1999;17:509-511
    • (1999) J Clin Oncol , vol.17 , pp. 509-511
    • Einhorn, L.H.1    Stender, M.J.2    Williams, S.D.3
  • 82
    • 0031894725 scopus 로고    scopus 로고
    • Early stage and advanced seminoma: Role of radiation therapy, surgery, and chemotherapy
    • Gospodarwicz MK, Sturgeon JF, Jewett MA. Early stage and advanced seminoma: Role of radiation therapy, surgery, and chemotherapy. Semin Oncol 1998;25:160-173
    • (1998) Semin Oncol , vol.25 , pp. 160-173
    • Gospodarwicz, M.K.1    Sturgeon, J.F.2    Jewett, M.A.3
  • 83
    • 0021888230 scopus 로고
    • Advanced seminoma: Treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8)
    • Peckham MJ, Horwich A, Hendry WF. Advanced seminoma: Treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8). Br J Cancer 1985;52:7-13.
    • (1985) Br J Cancer , vol.52 , pp. 7-13
    • Peckham, M.J.1    Horwich, A.2    Hendry, W.F.3
  • 84
    • 0036837270 scopus 로고    scopus 로고
    • Management of postchemotherapy residual masses in advanced seminoma
    • Flechon A, Bompas E, Biron P, Droz JP. Management of postchemotherapy residual masses in advanced seminoma. J Urol 2002;168:1975-1979
    • (2002) J Urol , vol.168 , pp. 1975-1979
    • Flechon, A.1    Bompas, E.2    Biron, P.3    Droz, J.P.4
  • 86
    • 0030863030 scopus 로고    scopus 로고
    • Vena caval resection for bulky metastatic germ cell tumors: An 18-year experience
    • Spitz A, Wilson TG, Kawachi MH, Ahlering TE, Skinner DG. Vena caval resection for bulky metastatic germ cell tumors: An 18-year experience. J Urol 1997;158:1813-1818
    • (1997) J Urol , vol.158 , pp. 1813-1818
    • Spitz, A.1    Wilson, T.G.2    Kawachi, M.H.3    Ahlering, T.E.4    Skinner, D.G.5
  • 87
    • 0038626293 scopus 로고    scopus 로고
    • Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?
    • Mosharafa AA, Foster RS, Leibovich BC, Bihrle R, Johnson C, Donohue JP. Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? J Urol 2003;169:2126-2128
    • (2003) J Urol , vol.169 , pp. 2126-2128
    • Mosharafa, A.A.1    Foster, R.S.2    Leibovich, B.C.3    Bihrle, R.4    Johnson, C.5    Donohue, J.P.6
  • 89
    • 0023684329 scopus 로고
    • Treatment of the residual retroperitoneal mass after chemotherapy for advanced seminoma
    • Ellison MF, Mostofi FK, Flanigan RC. Treatment of the residual retroperitoneal mass after chemotherapy for advanced seminoma. J Urol 1988;140:618-620
    • (1988) J Urol , vol.140 , pp. 618-620
    • Ellison, M.F.1    Mostofi, F.K.2    Flanigan, R.C.3
  • 92
    • 9044243757 scopus 로고    scopus 로고
    • Management of residual mass in advanced seminoma: Results and recommendations from the Memorial Sloan-Kettering Cancer Center
    • Puc HS, Heelan R, Mazumdar M, Herr H, Scheinfeld J, Vlamis V, et al. Management of residual mass in advanced seminoma: Results and recommendations from the Memorial Sloan-Kettering Cancer Center. J Clin Oncol 1996;14:454-460
    • (1996) J Clin Oncol , vol.14 , pp. 454-460
    • Puc, H.S.1    Heelan, R.2    Mazumdar, M.3    Herr, H.4    Scheinfeld, J.5    Vlamis, V.6
  • 93
    • 0023198254 scopus 로고
    • Residual mass after chemotherapy for seminoma: Changing concepts of management
    • Herr HW, Bosl G. Residual mass after chemotherapy for seminoma: Changing concepts of management. J Urol 1987;137:1234-1235
    • (1987) J Urol , vol.137 , pp. 1234-1235
    • Herr, H.W.1    Bosl, G.2
  • 94
    • 39149113090 scopus 로고    scopus 로고
    • The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma
    • Hinz S, Schrader M, Kempkensteffen C, Bares R, Brenner W, Krege S, et al. The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma. J Urol 2008;179:936-940
    • (2008) J Urol , vol.179 , pp. 936-940
    • Hinz, S.1    Schrader, M.2    Kempkensteffen, C.3    Bares, R.4    Brenner, W.5    Krege, S.6
  • 95
    • 1842509872 scopus 로고    scopus 로고
    • 2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: An update of the prospective multicentric SEMPET trial
    • De Santis M, Becherer A, Bokemeyer C, Stoiber F, Oechsle K, Sellner F, et al. 2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: An update of the prospective multicentric SEMPET trial. J Clin Oncol 2004;22:1034-1039
    • (2004) J Clin Oncol , vol.22 , pp. 1034-1039
    • De Santis, M.1    Becherer, A.2    Bokemeyer, C.3    Stoiber, F.4    Oechsle, K.5    Sellner, F.6
  • 96
    • 0032728818 scopus 로고    scopus 로고
    • Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma
    • Ganjoo KN, Chan RJ, Sharma M, Einhorn LH. Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma. J Clin Oncol 1999;17:3457-3460
    • (1999) J Clin Oncol , vol.17 , pp. 3457-3460
    • Ganjoo, K.N.1    Chan, R.J.2    Sharma, M.3    Einhorn, L.H.4
  • 97
    • 20244368226 scopus 로고    scopus 로고
    • FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals
    • Becherer A, De Santis M, Karanikas G, Szabó M, Bokemeyer C, Dohmen BM, et al. FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals. Eur J Radiol 2005;54:284-288
    • (2005) Eur J Radiol , vol.54 , pp. 284-288
    • Becherer, A.1    De Santis, M.2    Karanikas, G.3    Szabó, M.4    Bokemeyer, C.5    Dohmen, B.M.6
  • 98
    • 18144447926 scopus 로고    scopus 로고
    • Radiotherapy after chemotherapy for metastatic seminoma: A diminishing role, MRC Testicular Tumour Working Party
    • Duchesne GM, Stenning SP, Aass N, Mead GM, Fosså SD, Oliver RT, et al. Radiotherapy after chemotherapy for metastatic seminoma: A diminishing role, MRC Testicular Tumour Working Party. Eur J Cancer 1997;33:829-835
    • (1997) Eur J Cancer , vol.33 , pp. 829-835
    • Duchesne, G.M.1    Stenning, S.P.2    Aass, N.3    Mead, G.M.4    Fosså, S.D.5    Oliver, R.T.6
  • 99
    • 0038012184 scopus 로고    scopus 로고
    • Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage i seminoma
    • Aparicio J, García del Muro X, Maroto P, Paz-Ares L, Alba E, Sáenz A, et al. Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. Ann Oncol 2003;14:867-872
    • (2003) Ann Oncol , vol.14 , pp. 867-872
    • Aparicio, J.1    García Del Muro, X.2    Maroto, P.3    Paz-Ares, L.4    Alba, E.5    Sáenz, A.6
  • 101
    • 0026476291 scopus 로고
    • Orchidectomy followed by radiotherapy in 176 stage i and II testicular seminoma patients: Benefits of a 10-year follow-up study
    • Bayens YC, Helle PA, Van Putten WL, Mali SP. Orchidectomy followed by radiotherapy in 176 stage I and II testicular seminoma patients: Benefits of a 10-year follow-up study. Radiother Oncol 1992;25:97-102.
    • (1992) Radiother Oncol , vol.25 , pp. 97-102
    • Bayens, Y.C.1    Helle, P.A.2    Van Putten, W.L.3    Mali, S.P.4
  • 102
    • 0030955107 scopus 로고    scopus 로고
    • Long-term evaluation of postorchiectomy radiotherapy for stage II seminoma
    • Whipple GL, Sagerman RH, van Rooy EM. Long-term evaluation of postorchiectomy radiotherapy for stage II seminoma. Am J Clin Oncol 1997;20:196-201.
    • (1997) Am J Clin Oncol , vol.20 , pp. 196-201
    • Whipple, G.L.1    Sagerman, R.H.2    Van Rooy, E.M.3
  • 103
    • 0032726796 scopus 로고    scopus 로고
    • Prognostic factors in seminomas with special respect to HCG: Results of a prospective multicenter study: Seminoma Study Group
    • Weissbach L, Bussar-Maatz R, Löhrs U, Schubert GE, Mann K, Hartmann M, et al. Prognostic factors in seminomas with special respect to HCG: Results of a prospective multicenter study: Seminoma Study Group. Eur Urol 1999;36:601-608
    • (1999) Eur Urol , vol.36 , pp. 601-608
    • Weissbach, L.1    Bussar-Maatz, R.2    Löhrs, U.3    Schubert, G.E.4    Mann, K.5    Hartmann, M.6
  • 104
    • 0025057840 scopus 로고
    • Consensus statement on the investigation and management of testicular seminoma 1989
    • Thomas G, Jones W, VanOosterom A, Kawai T. Consensus statement on the investigation and management of testicular seminoma 1989. Prog Clin Biol Res 1990;357:285-294
    • (1990) Prog Clin Biol Res , vol.357 , pp. 285-294
    • Thomas, G.1    Jones, W.2    Vanoosterom, A.3    Kawai, T.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.